Moneycontrol PRO
Outskill Genai

business

Biocon-Mylan to file 4 drug applications in FY17 under rev-share

The company is going to submit data to US FDA and European authorities for approval in a few months time, says Kiran Mazumdar Shaw, CMD, Biocon.

first published: Jun 6, 2016 10:20 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347